<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">445334630</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180317142750.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170323e20111101xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1245/s10434-011-1767-3</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1245/s10434-011-1767-3</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Class III Nerve-sparing Radical Hysterectomy Versus Standard Class III Radical Hysterectomy: An Observational Study</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Antonino Ditto, Fabio Martinelli, Flavia Mattana, Claudio Reato, Eugenio Solima, Marialuisa Carcangiu, Edward Haeusler, Luigi Mariani, Francesco Raspagliesi]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Background: The purpose of this observational study was to evaluate disease-free survival, overall survival, local recurrence rate, and morbidities in patients submitted to class III nerve-sparing radical hysterectomy (NSRH) compared with standard radical hysterectomy (RH) in cervical cancer (CC). This was a comparative study in the context of multimodal therapies. Materials and Methods: We investigated patients with CC admitted to the National Cancer Institute of Milan between January 4, 2001, and September 29, 2009, treated with NSRH. We compared patients operated with RH between March 20, 1980, and December 28, 1995. A total of 496 patients were enrolled. The median follow-up was 93months (42 and 159months for the NSRH and RH groups, respectively). Results: The overall number of relapses was 30 out of 185 and 60 out of 311 for NSRH and RH, respectively. Five-year disease-free survival estimate was 78.9% (95% confidence interval [CI] 72.0-85.7) in NSRH and 79.8% (95% CI 75.3-84.3) in RH (P=0.519). Five-year overall survival estimate was 90.8% (95% CI 85.9-95.6) in NSRH and 84.1% (95% CI 8.0-88.3) in RH (P=0.192). Rates of postoperative serious complications were 9.7% and 19.6% for NSRH and RH, respectively (P=0.004). Positive pelvic lymph node and vagina status were significant (P&lt;0.01) independent predictors by multivariable analyses. Conclusions: The oncologic results were comparable between NSRH and conventional class III RH in the context of two multimodal treatments. Bladder function and postoperative complications rate are improved by nerve-sparing technique. The nerve-sparing technique should be considered in all CC patients addressed to surgery because it improves functional outcome and preserves radicality without compromising overall survival.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Society of Surgical Oncology, 2011</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Ditto</subfield>
   <subfield code="D">Antonino</subfield>
   <subfield code="u">Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Martinelli</subfield>
   <subfield code="D">Fabio</subfield>
   <subfield code="u">Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Mattana</subfield>
   <subfield code="D">Flavia</subfield>
   <subfield code="u">Unit of Clinical Epidemiology and Trial Organisation, IRCCS National Cancer Institute, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Reato</subfield>
   <subfield code="D">Claudio</subfield>
   <subfield code="u">Department of Obstetrics and Gynaecology, Treviglio/Caravaggio Hospital, Bergamo, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Solima</subfield>
   <subfield code="D">Eugenio</subfield>
   <subfield code="u">Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Carcangiu</subfield>
   <subfield code="D">Marialuisa</subfield>
   <subfield code="u">Department of Pathology, IRCCS National Cancer Institute, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Haeusler</subfield>
   <subfield code="D">Edward</subfield>
   <subfield code="u">Department of Anesthesiology, IRCCS National Cancer Institute, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Mariani</subfield>
   <subfield code="D">Luigi</subfield>
   <subfield code="u">Unit of Clinical Epidemiology and Trial Organisation, IRCCS National Cancer Institute, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Raspagliesi</subfield>
   <subfield code="D">Francesco</subfield>
   <subfield code="u">Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Annals of Surgical Oncology</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">18/12(2011-11-01), 3469-3478</subfield>
   <subfield code="x">1068-9265</subfield>
   <subfield code="q">18:12&lt;3469</subfield>
   <subfield code="1">2011</subfield>
   <subfield code="2">18</subfield>
   <subfield code="o">10434</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1245/s10434-011-1767-3</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1245/s10434-011-1767-3</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Ditto</subfield>
   <subfield code="D">Antonino</subfield>
   <subfield code="u">Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Martinelli</subfield>
   <subfield code="D">Fabio</subfield>
   <subfield code="u">Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Mattana</subfield>
   <subfield code="D">Flavia</subfield>
   <subfield code="u">Unit of Clinical Epidemiology and Trial Organisation, IRCCS National Cancer Institute, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Reato</subfield>
   <subfield code="D">Claudio</subfield>
   <subfield code="u">Department of Obstetrics and Gynaecology, Treviglio/Caravaggio Hospital, Bergamo, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Solima</subfield>
   <subfield code="D">Eugenio</subfield>
   <subfield code="u">Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Carcangiu</subfield>
   <subfield code="D">Marialuisa</subfield>
   <subfield code="u">Department of Pathology, IRCCS National Cancer Institute, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Haeusler</subfield>
   <subfield code="D">Edward</subfield>
   <subfield code="u">Department of Anesthesiology, IRCCS National Cancer Institute, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Mariani</subfield>
   <subfield code="D">Luigi</subfield>
   <subfield code="u">Unit of Clinical Epidemiology and Trial Organisation, IRCCS National Cancer Institute, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Raspagliesi</subfield>
   <subfield code="D">Francesco</subfield>
   <subfield code="u">Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Annals of Surgical Oncology</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">18/12(2011-11-01), 3469-3478</subfield>
   <subfield code="x">1068-9265</subfield>
   <subfield code="q">18:12&lt;3469</subfield>
   <subfield code="1">2011</subfield>
   <subfield code="2">18</subfield>
   <subfield code="o">10434</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
